Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs
Bullboard Posts
User Avatar Image
(0)
•••
Comment by wesdevrieson May 31, 2014 12:34am
203 Views
Post# 22617609

RE:RE:RE:RE:RE:bbb

RE:RE:RE:RE:RE:bbbYou make it easy "slick; tell me which one you are? And who said anything about $1.30 share, percentages, BTI or whatever stock? If you read my post again, I was giving you advice about you needing to learn to shut-up, learn some respect, contribute, quit acting like a child, think, and grow up...is that alot to ask! And that's just a start if you ever want to do a job like mine! If you were to read your own posts; I don't know if you would realise that you're incapable of thinking critically! You are cognitively "inept" in comprehending information even when it's laid out for you. You think you understand a "body of material" when you read it, but when you open your mouth...it's like you're fourteen years old and going through puberty! If you want attention...take your dress off and quit hiding behind an alias; I'll nurture you in more ways than one for you to start having a little bit more respect "on and off" location, but maybe you're also socially inept and you don't have the ability!
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities